logo

For the Inventor, By the Inventor

Mayenne, France

Jean-Pierre Pilleux

This inventor holds 5 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Pilleux. Retrieved from https://idiyas.com/inventor/jean-pierre-pilleux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal5 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 2008-2011

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7928125 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
2. 7928124 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-04-19),
3. 7897618 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-03-01),
4. 7893090 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2011-02-22),
5. 7470710 - N-aroyl cyclic amine derivatives as orexin receptor antagonists (2008-12-30),

Title: The Innovative Mind of Jean-Pierre Pilleux

Introduction

Jean-Pierre Pilleux, a prominent inventor based in Mayenne, France, is known for his significant contributions to the field of pharmaceuticals. With a portfolio that includes five patents, Pilleux has made strides in the development of novel compounds aimed at addressing critical health issues. His work highlights the importance of innovation in medical research and drug development.

Latest Patents

Among his latest contributions, Pilleux has patented N-aroyl cyclic amine derivatives as orexin receptor antagonists. These derivatives are recognized for their potential pharmaceutical application, particularly in the treatment of conditions related to the orexin receptor. The disclosed compounds have specific structural formulas that outline their potential uses in medical therapies. This work demonstrates not only Pilleux's innovative spirit but also his commitment to advancing healthcare solutions.

Career Highlights

Jean-Pierre Pilleux has dedicated his professional career to research and development within the pharmaceutical sector. He is currently affiliated with SmithKline Beecham Corporation, where he has been instrumental in pioneering new drug formulations. His inventive methodologies and persistent pursuit of knowledge have earned him recognition within the scientific community.

Collaborations

Pilleux has worked alongside notable colleagues such as Clive Leslie Branch and Wai Ngor Chan. These collaborations reflect the collaborative nature of scientific research, where ideas and expertise converge to foster innovation and implement effective solutions in the realm of pharmaceuticals.

Conclusion

In summary, Jean-Pierre Pilleux's contributions to pharmaceutical development through his patents underline his role as a significant inventor in the industry. His work as an orexin receptor antagonist developer illustrates the potential for innovative compounds to transform therapeutic practices, paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…